178 related articles for article (PubMed ID: 18443900)
1. Selective contrast enhancement of individual Alzheimer's disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Abeta42 for magnetic resonance molecular imaging.
Ramakrishnan M; Wengenack TM; Kandimalla KK; Curran GL; Gilles EJ; Ramirez-Alvarado M; Lin J; Garwood M; Jack CR; Poduslo JF
Pharm Res; 2008 Aug; 25(8):1861-72. PubMed ID: 18443900
[TBL] [Abstract][Full Text] [Related]
2. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques.
Poduslo JF; Ramakrishnan M; Holasek SS; Ramirez-Alvarado M; Kandimalla KK; Gilles EJ; Curran GL; Wengenack TM
J Neurochem; 2007 Jul; 102(2):420-33. PubMed ID: 17596213
[TBL] [Abstract][Full Text] [Related]
3. Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
Wadghiri YZ; Li J; Wang J; Hoang DM; Sun Y; Xu H; Tsui W; Li Y; Boutajangout A; Wang A; de Leon M; Wisniewski T
PLoS One; 2013; 8(2):e57097. PubMed ID: 23468919
[TBL] [Abstract][Full Text] [Related]
4. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer's disease using voxel-based analysis of amyloid plaques.
Kim JH; Ha TL; Im GH; Yang J; Seo SW; Chung JJ; Chae SY; Lee IS; Lee JH
Neuroreport; 2014 Mar; 25(4):211-8. PubMed ID: 24518227
[TBL] [Abstract][Full Text] [Related]
6. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
[TBL] [Abstract][Full Text] [Related]
7. Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
Yang J; Wadghiri YZ; Hoang DM; Tsui W; Sun Y; Chung E; Li Y; Wang A; de Leon M; Wisniewski T
Neuroimage; 2011 Apr; 55(4):1600-9. PubMed ID: 21255656
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
9. Fast in vivo imaging of amyloid plaques using μ-MRI Gd-staining combined with ultrasound-induced blood-brain barrier opening.
Santin MD; Debeir T; Bridal SL; Rooney T; Dhenain M
Neuroimage; 2013 Oct; 79():288-94. PubMed ID: 23660031
[TBL] [Abstract][Full Text] [Related]
10. Targeting vascular amyloid in arterioles of Alzheimer disease transgenic mice with amyloid β protein antibody-coated nanoparticles.
Poduslo JF; Hultman KL; Curran GL; Preboske GM; Chamberlain R; Marjańska M; Garwood M; Jack CR; Wengenack TM
J Neuropathol Exp Neurol; 2011 Aug; 70(8):653-61. PubMed ID: 21760540
[TBL] [Abstract][Full Text] [Related]
11. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
[TBL] [Abstract][Full Text] [Related]
12. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
[TBL] [Abstract][Full Text] [Related]
13. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
[TBL] [Abstract][Full Text] [Related]
14. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
[TBL] [Abstract][Full Text] [Related]
15. Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies.
Ramakrishnan M; Kandimalla KK; Wengenack TM; Howell KG; Poduslo JF
Biochemistry; 2009 Nov; 48(43):10405-15. PubMed ID: 19775170
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
17. Development of fluorescent probes that bind and stain amyloid plaques in Alzheimer's disease.
Jung SJ; Park SH; Lee EJ; Park JH; Kong YB; Rho JK; Hur MG; Yang SD; Park YD
Arch Pharm Res; 2015 Nov; 38(11):1992-8. PubMed ID: 26012373
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
Petiet A; Santin M; Bertrand A; Wiggins CJ; Petit F; Houitte D; Hantraye P; Benavides J; Debeir T; Rooney T; Dhenain M
Neurobiol Aging; 2012 Aug; 33(8):1533-44. PubMed ID: 21531045
[TBL] [Abstract][Full Text] [Related]
19. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
